Revenue: As of FY2025, the actual value is USD 0.EPS: As of FY2025, the actual value is USD 0.EBIT: As of FY2025, the actual value is USD -1.14 M.<h3>Operating Expenses</h3><ul><li>Consulting and Advisory Fees: $327,991 in 2025, a decrease from $731,128 in 2024, primarily due to reduced stock issuances for advisory board and legal services.</li><li>Related Party Consulting Fees: $438,000 in 2025, an increase from $388,000 in 2024, due to increased funds available for consulting fees.</li><li>General and Administrative Expenses: $309,107 in 2025, up from $282,249 in 2024, driven by increased expenses related to subsidiary BlueGreen Composites, LLC.</li><li>Professional Fees: $221,119 in 2025, down from $308,109 in 2024, due to higher auditing fees and legal costs in the prior period.</li><li>Research and Development Expenses: $69,274 in 2025, a decrease from $196,422 in 2024, due to reduced testing and initial product development costs.</li></ul><h3>Other Expenses</h3><ul><li>Interest Expense: $225,566 in 2025, compared to $1,183,885 in 2024, with the prior period including $1,070,729 in default interest related to the Auctus note.</li><li>Total Other Expenses: $281,407 in 2025, a decrease from $1,197,193 in 2024.</li></ul><h3>Net Loss</h3><ul><li>Net Loss: $1,646,898 in 2025, compared to $3,103,101 in 2024, primarily due to reduced operating expenses and lower interest expense.</li></ul><h3>Cash Flow</h3><ul><li>Operating Cash Flow: Net cash used in operating activities was $1,288,505 in 2025, compared to $1,430,345 in 2024.</li><li>Investing Cash Flow: Net cash used in investing activities was $1,762 in 2025, compared to $8,163 in 2024.</li><li>Financing Cash Flow: Net cash provided by financing activities was $682,000 in 2025, compared to $2,030,000 in 2024.</li></ul><h3>Outlook</h3>The company plans to raise capital through equity and debt to fund operations and eventually generate revenue through its business. Continued losses may adversely affect liquidity, raising substantial doubt about the ability to continue as a going concern.

Xeriant, Inc. | 10-K: FY2025 Revenue: USD 0